Product NDC: | 0781-5032 |
Proprietary Name: | Cyclobenzaprine Hydrochloride |
Non Proprietary Name: | Cyclobenzaprine Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Cyclobenzaprine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-5032 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072854 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060206 |
Package NDC: | 0781-5032-64 |
Package Description: | 10 TABLET, FILM COATED in 1 BLISTER PACK (0781-5032-64) |
NDC Code | 0781-5032-64 |
Proprietary Name | Cyclobenzaprine Hydrochloride |
Package Description | 10 TABLET, FILM COATED in 1 BLISTER PACK (0781-5032-64) |
Product NDC | 0781-5032 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cyclobenzaprine Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20060206 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |